Creative Proteomics Strengthens Protein Dynamics and Interaction Research Support With HDX-MS

Creative Proteomics has launched a dedicated HDX-MS service to help researchers study protein higher-order structure, conformational dynamics, and molecular interactions under solution-phase conditions. The offering supports applications such as epitope mapping, ligand binding analysis, comparability assessment, and formulation stability studies, with end-to-end support from study design through data interpretation. Intended for research use only, the service is designed to deliver practical, decision-ready insight into protein structural change, solvent accessibility, and interaction behavior.

eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

Phenomix Sciences Report Finds Patients See GLP-1s as Progress, Not a Cure; Want More Guidance on Long-Term Care

National survey shows patient expectations and perceptions of GLP-1s are evolving, and clearer education is shaping obesity treatment decisions.

Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions

New user interface provides visual insights to guide compound optimisation

iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids

Kindeva® commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’

Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back

Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases

Abselion Appoints Dale Gordon as Chair

Bioprocessing leader to drive continued commercial development and international expansion

Epigenica AB Expands Presence in Japan Through Distribution Agreement with PrimeTech

Epigenica AB today announced a distribution agreement with PrimeTech Co., Ltd., bringing Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market.

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

The team at ClearNote Health strengthened its leadership team with four key additions.

ZeOmega Recognized in the 2026 Gartner® Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations

QT9 Software Announces New Global Headquarters in Historic Downtown Batavia

Adaptive reuse project will transform century-old factory into modern tech campus

Huateng Pharma to Showcase High-Purity PEG Derivatives and CDMO Services at CPHI Japan 2026

Huateng Pharma (Hunan Huateng Pharmaceutical Co., Ltd.), a leading manufacturer of high-purity PEG derivatives, pharmaceutical intermediates and fine chemicals, today announced its participation in CPHI Japan 2026. The event will take place from April 21 to April 23 at Tokyo Big Sight.

Multi-Arm PEG Architectures Expand Options for Long-Acting Biologic Development

Biopharma PEG highlights high-purity multi-arm PEG reagents designed to support PEGylation research and therapeutic conjugation development

Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research

Silverstone, UK, 16 March 2026: Lab Thread Ltd, a UK‐based life science software company, today announced the release of a free of charge version of the Company’s Unified Lab Software Platform, available to academic and non-profit researchers worldwide. The software provides a range of core modules tailored to support early-stage research – offering an intuitive and collaborative system that enables users to quickly and easily implement robust data management plans within their own lab.

START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe

This partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research.

Arctoris Launches Biophysics Centre of Excellence to Bridge the AI-Experimentation Gap in Drug Discovery

Arctoris has launched a Biophysics Centre of Excellence featuring a tenfold expansion of biophysical instrumentation, including exclusive early access to the autonomous Instromeda SPRneo platform, to meet growing demand for high-quality experimental data in AI-driven drug discovery. The Centre also formalises strategic partnerships with Instromeda and SPRNexus, and welcomes internationally recognised biophysics expert Dr Iva Navratilova as Expert in Residence, establishing Arctoris as a global reference site for quantitative molecular interaction science at industrial scale.

DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science

DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company’s clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe’s broader growth objectives, including integration of newly acquired capabilities from Firstline.